• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·France·Healthcare·ALEMG.PA
Share

Laboratoires Euromedis Societe anonyme Stocks

€ 5.6Last Updated 19.10.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

€ 18.14M

€ 5.6
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Euromedis Groupe, a French company established in 1985 and based in Mouy, France, specializes in the development, manufacturing, and distribution of medical equipment. Operating under its proprietary Euromedis brand, the company caters to a broad clientele in France, including medical professionals, local public services, and private individuals. Its extensive product line encompasses a wide array of medical supplies. This includes sterile and non-sterile gloves, wound care essentials like dressings and compresses, and various medical kits. For parenteral care, it provides items such as needles, syringes, infusers, and catheters. The surgical range is comprehensive, featuring wound drainage products, probes, draping solutions for operating theaters, surgical gloves, and protective covers. Beyond these, Euromedis also offers oxygen therapy equipment, products for continence management and general hygiene, diagnostic tools, and a selection of home care necessities. In addition to its product offerings, Euromedis Groupe provides services such as the distribution and rental of medical equipment, as well as specialized in-home infusion and nutrition support. While primarily focused on the French market, the company has a significant international footprint, exporting its products to numerous countries including Belgium, Italy, Morocco, Ivory Coast, Gabon, Benin, Algeria, Ireland, the Netherlands, Portugal, Tunisia, Switzerland, the Czech Republic, the United Kingdom, Germany, Finland, Spain, Greece, Hungary, Lithuania, Latvia, Bulgaria, and Poland.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, underva

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of ALEMG.PA is 4.00 and suggests 28.6% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.10.2026 16:27

"Value Is More Important Than Volume": Why Jefferies Expects Kazatomprom Shares to Rise 69%

21.10.2026 16:10

Shares of software developer Braze soared 50%. Salesforce is set to acquire it for the "wow factor."

21.10.2026 15:51

It's Not Just the War: Morgan Stanley Doesn't Expect the Fuel Market to Ease Until Mid-2027

21.10.2026 15:46

Morning in New York: Stress Tests for the Tech Sector Continue

21.10.2026 15:46

Losses Exceeding $80 Billion and Rapidly Rising Costs: What the WSJ Learned from Anthropic's Prospectus

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026